These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20082752)

  • 1. [Gene polymorphism and physical constitution theory: starting point of exploring syndromes of lung cancer].
    Su W; Xu ZY
    Zhong Xi Yi Jie He Xue Bao; 2010 Jan; 8(1):15-9. PubMed ID: 20082752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene.
    Butkiewicz D; Popanda O; Risch A; Edler L; Dienemann H; Schulz V; Kayser K; Drings P; Bartsch H; Schmezer P
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2242-6. PubMed ID: 15598786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p53 codon 72 polymorphism and lung cancer risk.
    Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case report: an EML4-ALK positive lung adenocarcinoma diagnosed 
with lymphoma previously].
    Liu L; Heng W
    Zhongguo Fei Ai Za Zhi; 2015 Feb; 18(2):89-91. PubMed ID: 25676402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association of genetic polymorphism in the DNA repair gene XRCC1 with susceptibility to lung cancer in non-smoking women].
    Li MC; Cui ZS; He QC; Zhou BS
    Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):713-6. PubMed ID: 16483478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
    Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Approaches for developing a system model for health evaluation based on body constitutions of traditional Chinese medicine and order parameters].
    Huang C; Zhu YB; Liu ZJ
    Zhong Xi Yi Jie He Xue Bao; 2012 Apr; 10(4):375-9. PubMed ID: 22500709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between CYP1A2-T2467DELT polymorphism and smoking in adenocarcinoma and squamous cell carcinoma of the lung.
    Pavanello S; B'chir F; Pulliero A; Saguem S; Ben Fraj R; El Aziz Hayouni A; Clonfero E; Mastrangelo G
    Lung Cancer; 2007 Sep; 57(3):266-72. PubMed ID: 17509724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of evidence of association of p21WAF1/CIP1 polymorphism with lung cancer susceptibility and prognosis in Taiwan.
    Shih CM; Lin PT; Wang HC; Huang WC; Wang YC
    Jpn J Cancer Res; 2000 Jan; 91(1):9-15. PubMed ID: 10744039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of the association between glutathione S-transferase P1 gene polymorphism and the risk of adenocarcinomas of lung cancer.
    Zhong H; Feng Y; Zheng GX; Liang Y; Zhang JY; Zheng BS; Feng X
    Cancer Biomark; 2013; 13(1):29-35. PubMed ID: 23736019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility.
    Sunaga N; Kohno T; Yanagitani N; Sugimura H; Kunitoh H; Tamura T; Takei Y; Tsuchiya S; Saito R; Yokota J
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):730-8. PubMed ID: 12163326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.
    Wang H; Tan W; Hao B; Miao X; Zhou G; He F; Lin D
    Cancer Res; 2003 Nov; 63(22):8057-61. PubMed ID: 14633739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized medicine, health medicine, and constitutional theory in Chinese medicine.
    Wang Q
    Front Med; 2012 Mar; 6(1):1-7. PubMed ID: 22460443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China.
    Song N; Tan W; Xing D; Lin D
    Carcinogenesis; 2001 Jan; 22(1):11-6. PubMed ID: 11159735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung Adenocarcinoma in Never Smokers: Problems of Primary Prevention from Aspects of Susceptible Genes and Carcinogens.
    Okazaki I; Ishikawa S; Ando W; Sohara Y
    Anticancer Res; 2016 Dec; 36(12):6207-6224. PubMed ID: 27919939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Exploration of cancer biological characteristics in people with different five movements and six climates constitution based on pan-cancer Bulk RNA-Seq].
    Tang XH; Chu BW; Li CT; Wang YF; Xia ZH; Li ZM; Tian XY; Wang CY; Chen Q; Hao S; Tao W; Wang JM; Wu MH; Zheng XH
    Zhongguo Zhong Yao Za Zhi; 2024 Jun; 49(11):3095-3112. PubMed ID: 39041169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARP-1 rs3219073 polymorphism may contribute to susceptibility to lung cancer.
    Wang HT; Gao Y; Zhao YX; Yu H; Wang TL; Bai L; Chen YZ; Zhang HB; Zhou BS; Qu YL; Liu D; Chen Y
    Genet Test Mol Biomarkers; 2014 Nov; 18(11):736-40. PubMed ID: 25225750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP63 gene polymorphisms, cooking oil fume exposure and risk of lung adenocarcinoma in Chinese non-smoking females.
    Yin ZH; Cui ZG; Ren YW; Su M; Ma R; He QC; Zhou BS
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6519-22. PubMed ID: 24377560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Bernges U; Philipp M; Woitowitz HJ
    Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers.
    Dama E; Melocchi V; Dezi F; Pirroni S; Carletti RM; Brambilla D; Bertalot G; Casiraghi M; Maisonneuve P; Barberis M; Viale G; Vecchi M; Spaggiari L; Bianchi F; Di Fiore PP
    Clin Cancer Res; 2017 Jan; 23(1):62-72. PubMed ID: 27358486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.